Biostax (BTAX) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access BTAX Annual Balance Sheets →
Looking at balance sheet data from Biostax through Sep 30 2023 provides insight into Sep 30 2024's solvency and capital structure over time.
Quarterly Report, GAAP in USD millions
ITEM
(Sep 30 2024)
(Jun 30 2024) (Mar 31 2024) (Dec 31 2023) (Sep 30 2023)
Assets
Cash & cash equivalent0.00
Deposits Assets AS0.01
Cash & Short-term Investments0.00
Total Current Assets0.01
Other Assets, Noncurrent0.00
Patents And Licenses-
Total Assets0.01
Liabilities
Accounts Payable1.54
Accrued Liabilities, Current0.34
Derivative Liability, Current DE0.03
Short-term Debt1.16
Other Liabilities, Current2.26
Total Current Liabilities5.33
Total Long-term Debt0.00
Other liabilities, Noncurrent0.00
License Fees Payable Current-
Total Liabilities5.33
Stockholders' Equity
Common Stock Value0.01
Additional Paid In Capital Common Stock380.82
Retained Earnings / Accumulated Deficit-386.15
Other Equity0.00
Common Stockholder's Equity-5.32
Total Stockholder's Equity-5.32
Liabilities & Stockholder's Equity0.01
4 historic quarters locked

Sign in to unlock the full Biostax balance sheet history.

About Biostax Corp Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001376474-25-000322

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.